Literature DB >> 33441173

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy.

Woo Yeon Hwang1, Dong Hoon Suh1, Kidong Kim1, Jae Hong No1, Yong Beom Kim2.   

Abstract

BACKGROUND: To compare the diagnostic accuracy of aspiration biopsy and dilatation and curettage (D&C) in patients diagnosed with endometrial hyperplasia prior to hysterectomy.
METHODS: We retrospectively reviewed medical records of 250 patients diagnosed with endometrial hyperplasia by endometrial sampling between July 2003 and March 2020. Endometrial sampling was performed by aspiration biopsy (n = 150) or D&C (n = 100), followed by hysterectomy within 6 months. Pathological findings of hysterectomy specimens of the two groups were compared to preoperative findings.
RESULTS: The overall diagnostic concordance between endometrial sampling specimen including D&C and aspiration biopsy, and hysterectomy specimen was 51.0% (51/100) and 41.3% (62/150), respectively. Patients whose preoperative specimen was obtained by D&C were upgraded less significantly than those who underwent aspiration biopsy (21.0% vs 36.7%; P = 0.008). In particular, significantly fewer patients were upgraded after D&C than after aspiration biopsy in hyperplasia without atypia (12.5% vs 29.0%; P = 0.028). In addition, when the final pathological upgrade rate to endometrial carcinoma was evaluated between the two methods of endometrial sampling, significantly fewer cases were noted after D&C than after aspiration biopsy (15.0% vs 27.3%; P = 0.022).
CONCLUSIONS: In our study, D&C more accurately reflected the final diagnosis in patients with endometrial hyperplasia than aspiration biopsy based on the histological examination of hysterectomy specimens. When considering the management strategy for women with an endometrial hyperplasia diagnosis obtained by aspiration biopsy, physicians should consider the significant rate of upgraded diseases with this method of endometrial sampling.

Entities:  

Keywords:  Biopsy; Dilatation and curettage; Endometrial hyperplasia; Hysterectomy

Year:  2021        PMID: 33441173     DOI: 10.1186/s13000-020-01065-0

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  12 in total

1.  Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.

Authors:  Carla Merisio; Roberto Berretta; Andrea De Ioris; D Caterina Pultrone; Martino Rolla; Giovanna Giordano; Saverio Tateo; Mauro Melpignano
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-09-01       Impact factor: 2.435

2.  Pipelle endometrial sampling in patients with known endometrial carcinoma.

Authors:  T G Stovall; G J Photopulos; W M Poston; F W Ling; L G Sandles
Journal:  Obstet Gynecol       Date:  1991-06       Impact factor: 7.661

3.  Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C).

Authors:  Fuat Demirkiran; Evrim Yavuz; Hakan Erenel; Tugan Bese; Macit Arvas; Cevdet Sanioglu
Journal:  Arch Gynecol Obstet       Date:  2012-07-06       Impact factor: 2.344

4.  Comparison the Diagnostic Value of Dilatation and Curettage Versus Endometrial Biopsy by Pipelle--a Clinical Trial.

Authors:  Moradan Sanam; Mir Mohammad Khani Majid
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  The efficacy of the pipelle endometrial biopsy in detecting endometrial carcinoma.

Authors:  J Ferry; A Farnsworth; M Webster; B Wren
Journal:  Aust N Z J Obstet Gynaecol       Date:  1993-02       Impact factor: 2.100

6.  Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage.

Authors:  Elizabeth Suh-Burgmann; Yun-Yi Hung; Mary Anne Armstrong
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

7.  Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia.

Authors:  Pinar Kadirogullari; Cemal Resat Atalay; Ozhan Ozdemir; Mustafa Erkan Sari
Journal:  J Clin Diagn Res       Date:  2015-10-01

8.  Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage.

Authors:  Yan Yi; Cindy L Bryce; Shalkar Adambekov; Robert P Edwards; Sharon L Goughnour; Faina Linkov
Journal:  Gynecol Oncol       Date:  2018-05-07       Impact factor: 5.482

Review 9.  Therapeutic options for management of endometrial hyperplasia.

Authors:  Vishal Chandra; Jong Joo Kim; Doris Mangiaracina Benbrook; Anila Dwivedi; Rajani Rai
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

10.  Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.

Authors:  Mi Kyoung Kim; Seok Ju Seong; Dong Choon Park; Jin Hwa Hong; Ju Won Roh; Soon Beom Kang
Journal:  J Gynecol Oncol       Date:  2020-02-07       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.